Unknown

Dataset Information

0

Rapid response to cemiplimab for advanced cutaneous squamous cell carcinoma.

ABSTRACT:

SUBMITTER: Zargham H 

PROVIDER: S-EPMC9305312 | biostudies-literature | 2022 Aug

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

Rapid response to cemiplimab for advanced cutaneous squamous cell carcinoma.

Zargham Hanieh H   Strasswimmer John J  

JAAD case reports 20220606

Similar Datasets

Unknown Cemiplimab for advanced cutaneous squamous cell carcinoma in kidney transplant recipients.
| S-EPMC10479765 | biostudies-literature
Unknown Cemiplimab for Kidney Transplant Recipients With Advanced Cutaneous Squamous Cell Carcinoma.
| S-EPMC10950183 | biostudies-literature
Unknown Impact of cemiplimab treatment duration on clinical outcomes in advanced cutaneous squamous cell carcinoma.
| S-EPMC11162402 | biostudies-literature
Unknown Cemiplimab for the Treatment of Advanced Cutaneous Squamous Cell Carcinoma: Appropriate Patient Selection and Perspectives.
| S-EPMC10423569 | biostudies-literature
Unknown Cost-effectiveness analysis of cemiplimab vs pembrolizumab for treatment of advanced cutaneous squamous cell carcinoma.
| S-EPMC10394223 | biostudies-literature
Unknown Identifying candidates for immunotherapy with cemiplimab to treat advanced cutaneous squamous cell carcinoma: an expert opinion.
| S-EPMC8753075 | biostudies-literature
Unknown Neoadjuvant Cemiplimab for Stage II to IV Cutaneous Squamous-Cell Carcinoma.
| S-EPMC9844515 | biostudies-literature
Unknown IL-6 as new prognostic factor in patients with advanced cutaneous squamous cell carcinoma treated with cemiplimab
| S-EPMC9948392 | biostudies-literature
Unknown Case Series: Cemiplimab and Nivolumab Immunotherapy as Promising Treatment in Advanced or Metastatic Cutaneous Squamous Cell Carcinoma.
| S-EPMC10601823 | biostudies-literature
Unknown Anti-PD-1 therapy using cemiplimab for advanced cutaneous squamous cell carcinoma in HIV patient: A case report.
| S-EPMC8673230 | biostudies-literature